Translational Biotechnology : A Journey from Laboratory to Clinics
Front Cover -- Translational Biotechnology -- Copyright Page -- Contents -- List of contributors -- Preface -- 1 Introduction to translational biotechnology -- 1 Translational biotechnology: A transition from basic biology to evidence-based research -- 1.1 Introduction -- 1.1.1 Background and emergence of the field -- 1.2 The phases of translational research -- 1.3 Challenges to solutions -- 1.4 Applications -- 1.4.1 Drug development -- 1.4.1.1 Protein drugs -- 1.4.1.2 Hormones -- 1.4.1.3 Monoclonal antibodies -- 1.4.1.4 Cytokines -- 1.4.1.5 Vaccines -- 1.4.2 Nanomedicine -- 1.4.3 Gene therapy -- 1.4.4 Precision medicine and biomarker development -- 1.4.5 Microbial engineering for bio-therapeutics -- 1.4.6 Application of big data and translational bioinformatics -- 1.5 Conclusion and future directions -- 1.6 Highlights -- Acknowledgment -- Conflict of interest -- References -- 2 Biotherapeutics -- 2 Biotechnology-based therapeutics -- 2.1 Introduction -- 2.2 Human gene therapy -- 2.2.1 Somatic cell gene therapy -- 2.2.2 Germline gene therapy -- 2.2.3 Gene transfer system -- 2.2.3.1 Nonbiological delivery system -- 2.2.3.1.1 Physical method -- Sonoporation -- Electroporation -- Magnetofection -- Hydroporation -- Gene gun -- 2.2.3.1.2 Chemical method -- Liposomes -- Polymers -- Heat shock -- 2.2.3.1.3 Biological method -- Bacterial vector -- Viral vector -- Retroviral vectors -- Adenoviral vectors -- Adeno-associated vectors -- Herpes simplex virus -- 2.2.4 Gene-editing technology -- 2.2.4.1 Zinc-finger nucleases -- 2.2.4.2 Transcription activator-like effector nucleases -- 2.2.4.3 Clustered regularly interspaced short palindromic repeat-Cas-associated nucleases -- 2.2.5 Ethical issue -- 2.3 Stem cell therapy -- 2.3.1 Sources of stem cells -- 2.3.1.1 Pluripotent stem cells -- 2.3.1.2 Multipotent stem cells..
Medienart: |
E-Book |
---|
Erscheinungsjahr: |
2021 ©2021 |
---|---|
Erschienen: |
San Diego: Elsevier Science & Technology ; 2021 ©2021 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hasija, Yasha [VerfasserIn] |
---|
Links: |
ebookcentral.proquest.com [lizenzpflichtig] |
---|
ISBN: |
---|
Themen: |
---|
Anmerkungen: |
Description based on publisher supplied metadata and other sources |
---|
Umfang: |
1 online resource (453 pages) |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
1745949240 |
---|
LEADER | 01000cam a22002652 4500 | ||
---|---|---|---|
001 | 1745949240 | ||
003 | DE-627 | ||
005 | 20230426075026.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210128s2021 xx |||||o 00| ||eng c | ||
020 | |a 9780128219737 |9 978-0-12-821973-7 | ||
035 | |a (DE-627)1745949240 | ||
035 | |a (DE-599)KEP061130990 | ||
035 | |a (EBL)EBL6458431 | ||
035 | |a (EBC)EBC6458431 | ||
035 | |a (EBP)061130990 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
082 | 0 | |a 660.6 | |
100 | 1 | |a Hasija, Yasha |e verfasserin |4 aut | |
245 | 1 | 0 | |a Translational Biotechnology |b A Journey from Laboratory to Clinics |
264 | 1 | |a San Diego |b Elsevier Science & Technology |c 2021 | |
264 | 4 | |c ©2021 | |
300 | |a 1 online resource (453 pages) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Description based on publisher supplied metadata and other sources | ||
520 | |a Front Cover -- Translational Biotechnology -- Copyright Page -- Contents -- List of contributors -- Preface -- 1 Introduction to translational biotechnology -- 1 Translational biotechnology: A transition from basic biology to evidence-based research -- 1.1 Introduction -- 1.1.1 Background and emergence of the field -- 1.2 The phases of translational research -- 1.3 Challenges to solutions -- 1.4 Applications -- 1.4.1 Drug development -- 1.4.1.1 Protein drugs -- 1.4.1.2 Hormones -- 1.4.1.3 Monoclonal antibodies -- 1.4.1.4 Cytokines -- 1.4.1.5 Vaccines -- 1.4.2 Nanomedicine -- 1.4.3 Gene therapy -- 1.4.4 Precision medicine and biomarker development -- 1.4.5 Microbial engineering for bio-therapeutics -- 1.4.6 Application of big data and translational bioinformatics -- 1.5 Conclusion and future directions -- 1.6 Highlights -- Acknowledgment -- Conflict of interest -- References -- 2 Biotherapeutics -- 2 Biotechnology-based therapeutics -- 2.1 Introduction -- 2.2 Human gene therapy -- 2.2.1 Somatic cell gene therapy -- 2.2.2 Germline gene therapy -- 2.2.3 Gene transfer system -- 2.2.3.1 Nonbiological delivery system -- 2.2.3.1.1 Physical method -- Sonoporation -- Electroporation -- Magnetofection -- Hydroporation -- Gene gun -- 2.2.3.1.2 Chemical method -- Liposomes -- Polymers -- Heat shock -- 2.2.3.1.3 Biological method -- Bacterial vector -- Viral vector -- Retroviral vectors -- Adenoviral vectors -- Adeno-associated vectors -- Herpes simplex virus -- 2.2.4 Gene-editing technology -- 2.2.4.1 Zinc-finger nucleases -- 2.2.4.2 Transcription activator-like effector nucleases -- 2.2.4.3 Clustered regularly interspaced short palindromic repeat-Cas-associated nucleases -- 2.2.5 Ethical issue -- 2.3 Stem cell therapy -- 2.3.1 Sources of stem cells -- 2.3.1.1 Pluripotent stem cells -- 2.3.1.2 Multipotent stem cells. | ||
650 | 4 | |a Electronic books | |
776 | 1 | |z 9780128219720 | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780128219720 |
856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/kxp/detail.action?docID=6458431 |m X:EBC |x Aggregator |z lizenzpflichtig |
856 | 4 | 2 | |u https://www.gbv.de/dms/bowker/toc/9780128219720.pdf |v 2021-10-20 |x Aggregator |3 Inhaltsverzeichnis |
912 | |a ZDB-30-PQE | ||
912 | |a GBV_ILN_24 | ||
912 | |a ISIL_DE-8 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_736 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a ISIL_DE-289 | ||
951 | |a BO | ||
953 | |2 045F |a 660.6 | ||
980 | |2 24 |1 01 |x 0008 |b 3868368744 |h olr-ddaebc |k Diesen Titel können Sie über den Zugriffslink zunächst für kurze Zeit nutzen (1 Campuszugriff zur Zeit möglich) und bei weiterem Bedarf nach persönlicher Registrierung auf der nachfolgenden Seite der Zentralbibliothek zur dauerhaften Anschaffung vorschlagen. Wir werden Sie zügig über die Bereitstellung informieren. |y z |z 20-02-21 | ||
980 | |2 736 |1 01 |x 4736 |b 3845195568 |h EBC-Content |y zeg |z 29-01-21 | ||
980 | |2 2021 |1 01 |x DE-289 |b 3843977224 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |y l01 |z 28-01-21 | ||
981 | |2 24 |1 01 |x 0008 |r https://ebookcentral.proquest.com/lib/christianalbrechts/detail.action?docID=6458431 | ||
981 | |2 736 |1 01 |x 4736 |r https://ebookcentral.proquest.com/lib/staat/detail.action?docID=6458431 | ||
981 | |2 2021 |1 01 |x DE-289 |r https://ebookcentral.proquest.com/lib/kiz-uniulm/detail.action?docID=6458431 | ||
995 | |2 24 |1 01 |x 0008 |a olr-ddaebc | ||
995 | |2 736 |1 01 |x 4736 |a EBC-Content |